Gemeinschaftspraxis Jakobeit

Wipperfürth, North Rhine-Westphalia 51688

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed